The 3q29 microdeletion syndrome: Report of three new unrelated patients and in silico "RNA binding" analysis of the 3q29 region

American Journal of Medical Genetics, Part A

Volumn 155, Issue 7, 2011, Pages 1654-1660

  Dasouki, Majed J ^a   Lushington, Gerald H ^b   Hovanes, Karine ^c   Casey, James ^a   Gorre, Mereceds ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c CMDX   (United States)

Author keywords

3q29; ACGH; Chromosome; Deletion; In silico; RNA binding

Indexed keywords

RNA;

3Q29 MICRODELETION SYNDROME; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; CHROMOSOME DELETION 22Q11; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER MODEL; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; DLG1 GENE; FACE DYSMORPHIA; FAILURE TO THRIVE; FEMALE; GASTROESOPHAGEAL REFLUX; GENE; GENE DELETION; GENETIC DISORDER; HEART ATRIUM SEPTUM DEFECT; HEART MURMUR; HEMANGIOMA; HETEROZYGOSITY; HUMAN; IMMUNE DEFICIENCY; INGUINAL HERNIA; MALE; MICTURITION DISORDER; OTITIS MEDIA; PRIORITY JOURNAL; RIDDLE SYNDROME; RNA BINDING; RNF168 GENE; SCHOOL CHILD; SPEECH DISORDER;

ADOLESCENT; ADULT; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; MALE; PHENOTYPE; RNA; SYNDROME; YOUNG ADULT;

EID: 79959499946     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34080     Document Type: Article

References (45)

1. Alvarez AMC, Rivera H, Moller M, Valdivia A, Vigueras A, Cantu JM. 1984. De novo del(3)(q2800). Ann Genet 27: 109-111.
2. Ballif BC, Theisen A, Coppinger J, Gowans GC, Hersh JH, Madan-Khetarpal S, Schmidt KR, Tervo R, Escobar LF, Friedrich CA, McDonald M, Campbell L, Ming JE, Zackai EH, Bejjani BA, Shaffer LG. 2008. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet 1: 8.
3. Baynam G, Goldblatt J, Townshend S. 2006. A case of 3q29 microdeletion with novel features and a review of cytogenetically visible terminal 3q deletions. Clin Dysmorphol 15: 145-148.
4. Brueton LA, Barber JC, Huson SM, Winter RM. 1989. Partial monosomy 3q in a boy with short stature, developmental delay, and mild dysmorphic features. J Med Genet 26: 729-730.
5. Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH. 2006. Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci 29: 77-103.
6. Caruana G, Bernstein A. 2001. Craniofacial dysmorphogenesis including cleft palate in mice with an insertional mutation in the discs large gene. Mol Cell Biol 21: 1475-1483.
7. Chang S, Wen S, Chen D, Jin P. 2009. Small regulatory RNAs in neurodevelopmental disorders. Hum Mol Genet 18: R18-R26.
8. Chitayat D, Babul R, Silver MM, Jay V, Teshima IE, Babyn P, Becker LE. 1996. Terminal deletion of the long arm of chromosome 3 [46, XX, del(3)(q27-qter)]. Am J Med Genet 61: 45-48.
9. Clayton-Smith J, Giblin C, Smith RA, Dunn C, Willatt L. 2010. Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder. Clin Dysmorphol 19: 128-132.
10. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M. 2006. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38: 813-818.
11. Digilio M, Bernardini L, Mingarelli R, Capolino R, Capalbo A, Giuffrida M, Versacci P, Novelli A, Dallapiccola B. 2009. 3q29 Microdeletion: A mental retardation disorder unassociated with a recognizable phenotype in two mother-daughter Pairs. Am J Med Genet Part A 149A: 1777-1781.
12. Fabian MR, Sonenberg N, Filipowicz W. 2010. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
13. Georges M, Clop A, Marcq F, Takeda H, Pirottin D, Hiard S, Tordoir X, Caiment F, Meish F, Bibé B, Bouix J, Elsen JM, Eychenne F, Laville E, Larzul C, Milenkovic D, Tobin J, Charlier AC. 2006. Polymorphic microRNA target interactions: A novel source of phenotypic variation. Cold Spring Harb Symp Quant Biol 71: 343-350.
14. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. 2004. Detection of large-scale variation in the human genome. Nat Genet 36: 351-949.
15. Jin P, Alisch RS, Warren ST. 2004. RNA and microRNAs in fragile X mental retardation. Nat Cell Biol 6: 1048-1053.
16. Jokiaho I, Salo A, Niemi KM, Blomstedt GC, Pihkala J. 1989. Deletion 3q27-3qter in an infant with mild dysmorphism, parietal meningocele, and neonatal miliaria rubra-like lesions. Hum Genet 83: 302-304.
17. Kim VN, Han J, Siomi MC. 2009. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139.
18. Koolen DA, Nillesen WM, Versteeg MH, Merkx GF, Knoers NV, Kets M, Vermeer S, van Ravenswaaij CM, de Kovel CG, Brunner HG, Smeets D, de Vries BB, Sistermans EA. 2004. Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA). J Med Genet 41: 892-899.
19. Kreis P, Rousseau V, Thévenot E, Combeau G, Barnier JV. 2008. The four mammalian splice variants encoded by the p21-activated kinase 3 gene have different biological properties. J Neurochem 106: 1184-1197.
20. Krepischi-Santos AC, Vianna-Morgante AM, Jehee FS, Passos-Bueno MR, Knijnenburg J, Szuhai K, Sloos W, Mazzeu JF, Kok F, Cheroki C, Otto PA, Mingroni-Netto RC, Varela M, Koiffmann C, Kim CA, Bertola DR, Pearson PL, Rosenberg C. 2006. Whole-genome array-CGH screening in undiagnosed syndromic patients: Old syndromes revisited and new alterations. Cytogenet Genome Res 115: 254-261.
21. Kumar M, Gromiha MM, Raghava GPS. 2008. Prediction of RNA binding sites in a protein using SVM and PSSM profile. Proteins 71: 189-194.
22. Laverty HG, Wilson JB. 1998. Murine CASK is disrupted in a sex-linked cleft palate mouse mutant. Genomics 53: 29-41.
23. Li F, Lisi E, Wohler E, Hamosh A, Batista D. 2009. 3q29 interstitial microdeletion syndrome: An inherited case associated with cardiac defect and normal cognition. Eur J Med Genet 52: 349-352.
24. Mihçi E, Ozcan M, Berker-Karaüzüm S, Keser I, Taçoy S, Hapsolat S, Lüleci G. 2009. Subtelomeric rearrangements of dysmorphic children with idiopathic mental retardation reveal 8 different chromosomal anomalies. Turk J Pediatr 51: 453-459.
25. Nahas SA, Gatti RA. 2009. DNA double strand break repair defects, primary immunodeficiency disorders, and 'radiosensitivity'. Curr Opin Allergy Clin Immunol 9: 510-516.
26. Nakagawa T, Futai K, Lashuel H, Lo I, Okamoto K, Walz T, Hayashi Y, Sheng M. 2004. Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions. Neuron 44: 453-467.
27. Pinato S, Scandiuzzi C, Arnaudo N, Citterio E, Gaudino G, Penengo L. 2009. RNF168, a new RING finger, MIU-containing protein that modifies chromatin by ubiquitination of histones H2A and H2AX. BMC Mol Biol 10: 55.
28. Pollazzon M, Grosso S, Papaa F, Katzaki E, Marozza A, Mencarelli M, Uliana V, Balestri P, Mari F, Renieri A. 2009. A 9.3Mb microdeletion of 3q27.3q29 associated with psychomotor and growth delay, tricuspid valve dysplasia and bifid thumb. Eur J Med Genet 52: 131-133.
29. Quintero-Rivera F, Sharifi-Hannauer P, Martinez-Agosto JA. 2010. Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: Case report and review. Am J Med Genet Part A 152A: 2459-2467.
30. Qurashi A, Chang S, Peng J. 2007. Role of microRNA pathway in mental retardation. Sci WorldJ 7: 146-154.
31. Qurashi A, Jin P. 2010. Small RNA-mediated gene regulation in neurodevelopmental disorders. Curr Psychiatry Rep 12: 154-161.
32. Rossi E, Piccini F, Zollino M, Neri G, Caselli D, Tenconi R, Castellan C, Carrozzo R, Danesino C, Zuffardi O, Ragusa A, Castiglia L, Galesi O, Greco D, Romano C, Pierluigi M, Perfumo C, Di Rocco M, Faravelli F, Dagna Bricarelli F, Bonaglia M, Bedeschi M, Borgatti R. 2001. Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet 38: 417-420.
33. Sargent C, Burn J, Baraitser M, Pembrey ME. 1985. Trigonocephaly and the Opitz C syndrome. J Med Genet 22: 39-45.
34. Senzaki H, Inui M, Ban S, Masutani S, Morsy M, Kobayashi T, Nagasaka H, Sasaki N, Kyo S, Yokote Y. 2003. Dilated cardiomyopathy in a 3-year-old girl with a terminal deletion, 46, XX, del(3)(q27-qter), of the long arm of chromosome 3. Eur J Pediatr 162: 403-405.
35. Shao L, Shaw CA, Lu XY, Sahoo T, Bacino CA, Lalani SR, Stankiewicz P, Yatsenko SA, Li Y, Neill S, Pursley AN, Chinault AC, Patel A, Beaudet AL, Lupski JR, Cheung SW. 2008. Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: A study of 5, 380 cases. Am J Med Genet Part A 146: 2242-2251.
36. Stark KL, Xu B, Bagchi A, Lai WS, Liu H, Hsu R, Wan X, Pavlidis P, Mills AA, Karayiorgou M, Gogos JA. 2008. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 40: 751-760.
37. Stefani G, Slack FJ. 2008. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230.
38. Stewart GS, Stankovic T, Byrd PJ, Wechsler T, Miller ES, Huissoon A, Drayson MT, West SC, Elledge SJ, Taylor AM. 2007. RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc Natl Acad Sci 104: 16910-16915.
39. Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, Nakada S, Ylanko J, Olivarius S, Mendez M, Oldreive C, Wildenhain J, Tagliaferro A, Pelletier L, Taubenheim N, Durandy A, Byrd PJ, Stankovic T, Taylor AM, Durocher D. 2009. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 136: 420-434.
40. Stewart GS. 2009. Solving the RIDDLE of 53BP1 recruitment to sites of damage. Cell Cycle 8: 1532-1538.
41. Terribilini M, Sander JD, Lee JH, Zaback P, Jernigan RL, Honavar V, Dobbs D. 2007. RNABindR: A server for analyzing and predicting RNA-binding sites in proteins. Nucleic Acids Res 35: W578-584.
42. Tyshchenko N, Hackmann K, Gerlach E, Neuhann T, Schrock E, Tinschert S. 2009. 1.6Mb deletion in chromosome band 3q29 associated with eye abnormalities. Eur J Med Genet 52: 128-130.
43. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. 2007. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 39: 380-385.
44. Wang JC, Naik H, Khan A, Nowaczyk MJ. 2010. An uncommon 3.4-Mb interstitial deletion at 3q29. Clin Dysmorphol 19: 133-136.
45. Willatt L, Cox J, Barber J, Dachs Cabanas E, Collins A, Donnai D, FitzPatrick DR, Maher E, Martin H, Parnau J, Pindar L, Ramsay J, Shaw-Smith C, Sistermans EA, Tettenborn M, Trump D, de Vries BBA, Walker K, Raymond FL. 2005. 3q29 microdeletion syndrome: Clinical and molecular characterization of a new syndrome. Am J Hum Genet 77: 154-160.